Multi-center, multi-vendor validation of deep learning-based attenuation correction in SPECT MPI: data from the international flurpiridaz-301 trial.
Tomoe HagioJonathan B MoodyAlexis Poitrasson-RivièreJennifer M RenaudLora PierceChristopher BuckleyEdward P FicaroVenkatesh L MurthyPublished in: European journal of nuclear medicine and molecular imaging (2022)
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD, ClinicalTrials.gov Identifier: NCT01347710, registered on 4 May 2011. https://clinicaltrials.gov/ct2/show/study/NCT01347710.